Li Pan

1.1k total citations
40 papers, 844 citations indexed

About

Li Pan is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Li Pan has authored 40 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Li Pan's work include melanin and skin pigmentation (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Cancer-related Molecular Pathways (5 papers). Li Pan is often cited by papers focused on melanin and skin pigmentation (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Cancer-related Molecular Pathways (5 papers). Li Pan collaborates with scholars based in China, United States and Australia. Li Pan's co-authors include Lei Wu, Churong Li, Jiayuh Lin, Ling Hou, Jin Yang, Huirong Li, Shengling Fu, A. Douglas Kinghorn, Xiaoyin Ma and Jia Qu and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Human Molecular Genetics.

In The Last Decade

Li Pan

39 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Pan China 18 440 260 118 114 101 40 844
Qing Xiang China 14 365 0.8× 233 0.9× 114 1.0× 106 0.9× 55 0.5× 38 762
M Korabiowska Germany 18 471 1.1× 313 1.2× 149 1.3× 161 1.4× 166 1.6× 80 1.1k
Dan Yue China 19 406 0.9× 147 0.6× 158 1.3× 127 1.1× 45 0.4× 41 787
Liwei Lang United States 20 564 1.3× 173 0.7× 120 1.0× 202 1.8× 44 0.4× 52 940
Esra Gündüz Japan 21 858 1.9× 397 1.5× 105 0.9× 240 2.1× 93 0.9× 70 1.3k
Benoît Thibault France 12 409 0.9× 312 1.2× 160 1.4× 185 1.6× 63 0.6× 21 797
Cheng‐Yu Wu China 15 494 1.1× 270 1.0× 165 1.4× 100 0.9× 56 0.6× 35 899
Xiaoan Tao China 17 485 1.1× 209 0.8× 182 1.5× 349 3.1× 55 0.5× 41 977
Tianrun Liu China 13 399 0.9× 307 1.2× 209 1.8× 239 2.1× 47 0.5× 43 928

Countries citing papers authored by Li Pan

Since Specialization
Citations

This map shows the geographic impact of Li Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Pan more than expected).

Fields of papers citing papers by Li Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Pan. The network helps show where Li Pan may publish in the future.

Co-authorship network of co-authors of Li Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Li Pan. A scholar is included among the top collaborators of Li Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Pan. Li Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Nan, Keyu Li, Jun-Ke Wang, et al.. (2025). Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer. Biomarker Research. 13(1). 21–21. 2 indexed citations
2.
3.
Pan, Li, et al.. (2024). Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathway. Bioorganic Chemistry. 153. 107968–107968. 2 indexed citations
4.
Pan, Li, et al.. (2023). Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 28(2). 677–677. 5 indexed citations
5.
Chen, Xiang, Li Pan, Jia Wei, et al.. (2021). LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells. Scientific Reports. 11(1). 6517–6517. 14 indexed citations
6.
Guo, Qianqian, Wang Liu, Aihua Zhang, et al.. (2019). Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value. Clinical & Experimental Immunology. 199(2). 172–181. 52 indexed citations
7.
Pan, Li, et al.. (2019). <p>Distribution of circulating tumor cell phenotype in early cervical cancer</p>. Cancer Management and Research. Volume 11. 5531–5536. 22 indexed citations
8.
Tian, Jilai, Xiang Chen, Shengling Fu, et al.. (2019). Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer. Breast Cancer Research and Treatment. 175(3). 553–566. 59 indexed citations
9.
Pan, Li, Jennifer M. Huang, Ferenc Livák, et al.. (2019). CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties. PLoS Genetics. 15(4). e1008034–e1008034. 33 indexed citations
10.
Pan, Li, et al.. (2018). Integrin alpha5beta1 suppresses rBMSCs anoikis and promotes nitric oxide production. Biomedicine & Pharmacotherapy. 99. 1–8. 27 indexed citations
11.
Pan, Li, Hongli Yang, Cong Xu, et al.. (2018). ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment. Biomedicine & Pharmacotherapy. 105. 566–572. 19 indexed citations
12.
Ma, Xiaoyin, Huirong Li, Yipin Wang, et al.. (2017). DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epithelium. Human Molecular Genetics. 26(9). 1612–1621. 23 indexed citations
13.
Pan, Li, et al.. (2017). Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients. Oncology Research and Treatment. 40(11). 702–706. 2 indexed citations
14.
Pan, Li, et al.. (2017). PIM1: a promising target in patients with triple-negative breast cancer. Medical Oncology. 34(8). 142–142. 38 indexed citations
15.
Chen, Yu, Li Pan, Jing Wang, et al.. (2016). The transcription factor TBX2 regulates melanogenesis in melanocytes by repressing Oca2. Molecular and Cellular Biochemistry. 415(1-2). 103–109. 8 indexed citations
16.
Chen, Haiying, Hongli Yang, Pádraig Strappe, et al.. (2016). Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension. Heart Lung and Circulation. 26(5). 509–518. 17 indexed citations
17.
Chen, Haiying, Juan Wang, Wei Liu, et al.. (2014). Effect of diabetic osteoblasts on osteogenic differentiation of human umbilical cord mesenchymal stem cells. Biomedical Papers. 159(3). 388–393. 4 indexed citations
18.
Pan, Li, Feng Chen, Xianxian Zhao, et al.. (2012). Occurrence and clinical significance of in-hospital acquired thrombocytopenia in patients undergoing transcatheter device closure for congenital heart defect. Thrombosis Research. 130(6). 882–888. 9 indexed citations
19.
Gupta, Sneha, Ellen J. Sass, Melanie E. Davis, et al.. (2011). Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells. The AAPS Journal. 13(3). 357–64. 63 indexed citations
20.
Ma, Xiaoyin, Li Pan, Xi Jin, et al.. (2011). Microphthalmia-associated transcription factor acts through PEDF to regulate RPE cell migration. Experimental Cell Research. 318(3). 251–261. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Xiang Breakdown of academic impact, for papers by M Korabiowska Breakdown of academic impact, for papers by Dan Yue Breakdown of academic impact, for papers by Liwei Lang Breakdown of academic impact, for papers by Esra Gündüz Breakdown of academic impact, for papers by Benoît Thibault Breakdown of academic impact, for papers by Cheng‐Yu Wu Breakdown of academic impact, for papers by Xiaoan Tao Breakdown of academic impact, for papers by Tianrun Liu
Rankless by CCL
2026